Case Western Reserve University , USA
Qinglai Meng is a research associate working in Case Western Reserve University, United States. His research focused on immunopathogenesis during HIV infection, HCV infection or HIV/TB co-infection. Currently, he is working on immunotherapy of HIV latent infection. He obtained the Ph.D. degree in microbiology from Wuhan Institute of Virology, Chinese Academy of Science, where he developed and evaluated various vaccines of an equine lentivirus (EIAV). He has expertise in viral immunology and vaccine development.
NK cells oriented immunotherapy against virus infection or tumor
Vaccines against virus infection
Immunopathogenesis of HCV, HIV infection or HIV/TB co-infection